Peptide price index — Q3 2026
A market snapshot of per-milligram peptide pricing across 53 peptides with verified pricing data, computed from scraped research-vendor prices, normalized to milligrams, and winsorized to remove outliers. Figures describe the research-chemical market and are not a clinical pricing reference.
53
Peptides tracked
$5.00/mg
Market median
693.7×
Price dispersion
1,276
Vendor observations
Median per-mg prices span 693.7× across the index — from $0.148/mg at the low end to $102.67/mg at the high end — reflecting wide variation in synthesis complexity and vendor positioning.
Top price movers
Largest changes in median per-mg price over the tracked history window (earliest vs. latest recorded day).
| Peptide | Was | Now | Change |
|---|---|---|---|
| AICAR | $0.900 | $8.35 | +828% |
| glutathione | $0.080 | $0.450 | +462.5% |
| NAD+ | $0.147 | $0.700 | +376.1% |
| Semaglutide | $8.00 | $1.14 | -85.8% |
| Hexarelin | $4.96 | $8.40 | +69.2% |
| Foxo4-DRI | $20.00 | $10.47 | -47.7% |
| Oxytocin | $4.50 | $6.46 | +43.5% |
| SS-31 | $6.00 | $3.67 | -38.8% |
| SNAP-8 | $3.30 | $2.04 | -38.3% |
| Sermorelin | $5.00 | $6.80 | +36% |
Pricing by category
| Category | Peptides | Median $/mg | Range $/mg |
|---|---|---|---|
| Skin Joint | 3 | $2.87 | $0.706–$3.30 |
| Longevity | 14 | $3.25 | $0.148–$18.00 |
| Cognitive | 6 | $4.50 | $0.833–$8.00 |
| Sexual Health | 4 | $4.95 | $3.90–$7.90 |
| Recovery | 8 | $7.22 | $2.95–$18.45 |
| Performance | 9 | $8.00 | $1.10–$102.67 |
| Fat Loss | 9 | $8.90 | $2.56–$10.63 |
Methodology
Prices are scraped from research-vendor product listings, normalized to a per-milligram basis, and winsorized to the 5th–95th percentile to remove outliers. A peptide qualifies for this study only when it has priced listings from at least five distinct active vendors. Percentiles (p25, median, p75) are SQL aggregates — not curated or hand-ranked.
Placement in this study: 0 paid placements.
PeptideBase accepts no payment for inclusion in this study.
PeptideBase takes no affiliate commission on vendor sales.
Top movers compare the earliest and latest recorded daily median per-mg price for each peptide over the accumulated history window. Category figures are the median of per-peptide medians within each category.
Most prices reflect research-use vendors, whose products are sold for research purposes only and are not intended for human use. Clinical program pricing (telehealth, compounding pharmacy with prescription) follows a different model and is not captured here. Do not use this study as a clinical pricing reference. This is educational and informational content, not medical advice.
Cite this page
Data last updated August 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Peptide Price Index — Q3 2026 Market Study. Retrieved September 11, 2026, from https://peptidebase.io/data/peptide-price-index-q3-2026